Louvain-la-Neuve, Belgium, 04 April, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle ...

Tri-Service General Hospital in Taiwan has entered a contract with Ion Beam Applications (IBA) for a ProteusONE compact ...

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today ...

By merging their respective expertise in therapy and image guidance systems, IBA and Philips will work to develop more efficient, personalised cancer care. High quality imaging and proton therapy ...

Louvain-La-Neuve, Belgium, April 2 nd, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy ...

Louvain-La-Neuve, Belgium, April 2 nd, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy ...

Louvain-la-Neuve, Belgium, March 31st, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA ...

New Delhi: Hospital chain, Apollo Hospitals, has partnered with Belgium-based Ion Beam Applications (IBA), for its Proton Beam Therapy (PBT) based Proteus One system in India. Earlier in 2019 ...

We are pleased by the accelerated momentum in the Proton Therapy commercial activities as from the second half of 2024. A few other elements are worth mentioning. IBA continues to invest in the ...